clinical trial · NCT06717334
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
Lung Cancer ScreeningLow Dose CT imagingblood drawsscreening questionnaire
brief summary
The researchers are doing this study to see if people with unexplained weight loss who have lung cancer screening are more likely to have or develop lung cancer than people without unexplained weight loss. The lung cancer screening will involve use of low-dose computed tomography (LDCT), a CT scan that gives off very low doses of radiation and can make detailed pictures of the lungs to help find tumors. The study researchers will also analyze participants' blood samples to determine if blood testing can be used to help to diagnose lung cancer.
started
Dec 2, 2024
primary completion
Dec 1, 2027
completion
Dec 1, 2027
last updated
Sep 4, 2026
official title
Enrichment of Lung Cancer Screening Through Unexplained Weight Loss (UWL) to Stage Shift and Improve Survival
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol